Jiwon Oh1, Angela Vidal-Jordana2, Xavier Montalban1,2. 1. Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. 2. Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Servei de Neurologia-Neuroinmunologia, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
Abstract
PURPOSE OF REVIEW: Multiple sclerosis is a chronic, predominantly immune-mediated disease of the central nervous system, and one of the most common causes of neurological disability in young adults globally. This review will discuss the epidemiology, diagnosis, disease course, and prognosis of multiple sclerosis and will focus on recent evidence and advances in these aspects of the disease. RECENT FINDINGS: Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence regions of the world. Recent revisions have been proposed to the existing multiple sclerosis diagnostic criteria, which will facilitate earlier diagnosis and treatment in appropriate patients. Classifying multiple sclerosis into distinct disease phenotypes can be challenging, and recent refinements have been proposed to clarify existing definitions. The prognosis of multiple sclerosis varies substantially across individual patients, and a combination of clinical, imaging, and laboratory markers can be useful in predicting clinical course and optimizing treatment in individual patients. SUMMARY: A number of recent advances have been made in the clinical diagnosis and prognostication of multiple sclerosis patients. Future research will enable the development of more accurate biomarkers of disease categorization and prognosis, which will enable timely personalized treatment in individual multiple sclerosis patients.
PURPOSE OF REVIEW: Multiple sclerosis is a chronic, predominantly immune-mediated disease of the central nervous system, and one of the most common causes of neurological disability in young adults globally. This review will discuss the epidemiology, diagnosis, disease course, and prognosis of multiple sclerosis and will focus on recent evidence and advances in these aspects of the disease. RECENT FINDINGS:Multiple sclerosis is increasing in incidence and prevalence globally, even in traditionally low-prevalence regions of the world. Recent revisions have been proposed to the existing multiple sclerosis diagnostic criteria, which will facilitate earlier diagnosis and treatment in appropriate patients. Classifying multiple sclerosis into distinct disease phenotypes can be challenging, and recent refinements have been proposed to clarify existing definitions. The prognosis of multiple sclerosis varies substantially across individual patients, and a combination of clinical, imaging, and laboratory markers can be useful in predicting clinical course and optimizing treatment in individual patients. SUMMARY: A number of recent advances have been made in the clinical diagnosis and prognostication of multiple sclerosispatients. Future research will enable the development of more accurate biomarkers of disease categorization and prognosis, which will enable timely personalized treatment in individual multiple sclerosispatients.
Authors: Damiano Paolicelli; Giuseppe Lucisano; Alessia Manni; Carlo Avolio; Simona Bonavita; Vincenzo Brescia Morra; Marco Capobianco; Eleonora Cocco; Antonella Conte; Giovanna De Luca; Francesca De Robertis; Claudio Gasperini; Maurizia Gatto; Paola Gazzola; Giacomo Lus; Antonio Iaffaldano; Pietro Iaffaldano; Davide Maimone; Giulia Mallucci; Giorgia T Maniscalco; Girolama A Marfia; Francesco Patti; Ilaria Pesci; Carlo Pozzilli; Marco Rovaris; Giuseppe Salemi; Marco Salvetti; Daniele Spitaleri; Rocco Totaro; Mauro Zaffaroni; Giancarlo Comi; Maria Pia Amato; Maria Trojano Journal: J Neurol Date: 2019-09-18 Impact factor: 4.849
Authors: Jana Pöttgen; Wim van de Vis; An van Nunen; Anita Rose; Jannie Engelbrecht; Michelle Pirard; Stephanie Lau; Christoph Heesen; Sascha Köpke Journal: Int J MS Care Date: 2020-12-28
Authors: Wen-Tsan Weng; Ping-Chang Kuo; Dennis A Brown; Barbara A Scofield; Destin Furnas; Hallel C Paraiso; Pei-Yu Wang; I-Chen Yu; Jui-Hung Yen Journal: J Neuroinflammation Date: 2021-05-11 Impact factor: 8.322
Authors: Maria Luca; Clara Grazia Chisari; Aurora Zanghì; Francesco Patti Journal: Int J Environ Res Public Health Date: 2021-05-24 Impact factor: 3.390
Authors: Amnon A Berger; Emily R Sottosanti; Ariel Winnick; Jonathan Izygon; Kevin Berardino; Elyse M Cornett; Alan D Kaye; Giustino Varrassi; Omar Viswanath; Ivan Urits Journal: Neurol Int Date: 2021-05-19